Qube Research & Technologies (QRT)
LTRN icon

Qube Research & Technologies (QRT)’s Lantern Pharma LTRN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$10 – 3777
2024
Q2 		$10 Sell
2
-1,700
-100% -$10.2K ﹤0.01% 3611
2024
Q1 		$15K Buy
1,702
+1,700
+85,000% +$9.08K ﹤0.01% 3745
2023
Q4 		$9 Hold
2
– – ﹤0.01% 4174
2023
Q3 		$7 Buy
+2
New +$9 ﹤0.01% 3949

Other funds holding LTRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LTRN Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Lantern Pharma (LTRN) in Q3 2024, closing a stake of 2 shares — an estimated $10 sold.

Qube Research & Technologies (QRT) first reported a position in LTRN in Q3 2023 and held it in 4 quarters. The position peaked at $15K in Q1 2024. 31 funds tracked by Wall St. Rank hold LTRN as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Lantern Pharma position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2 Lantern Pharma shares in Q3 2024, an estimated $10.
  • Qube Research & Technologies (QRT) first reported a position in Lantern Pharma in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Lantern Pharma position peaked at $15K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.